A positive cannabis test can lead to an abrupt suspension, a withdrawn job offer, or a termination notice. In New Jersey, however, the label on that notice does not by itself identify the rule that applies: a result reflecting past use, alleged impairment during work, and a federally regulated assignment call for different questions.
The useful starting point is not simply whether cannabis is legal in New Jersey. It is identifying which account of the event the employer is actually using, then comparing the stated reason and supporting record to that account.
Start by placing the event in the right scenario
| Employer’s account | Central question | Why the distinction matters |
| A metabolite-only result | Was the employment decision based solely on cannabinoid metabolites from conduct permitted by New Jersey law? | State law says an employee may not face adverse action solely for those metabolites. |
| Claimed workplace impairment | What timely evidence, apart from the laboratory result, does the employer identify from prescribed work hours? | Testing can be allowed in several settings, but the NJ-CRC says metabolites alone are insufficient to support adverse action. |
| A federally regulated duty | Is the employee actually subject to a federal testing requirement or a qualifying federal-contract rule? | A separate federal regime may require removal from a particular duty after a verified positive test. |
These are comparison points, not three automatic outcomes. The same employee may have a positive test and an employer allegation about conduct at work. The decisive question is still what the employer says it relied on, what the role requires, and what contemporaneous evidence exists. A broad reference to a “drug-free workplace” policy may describe the employer’s policy goal without resolving those separate questions.
CREAMMA, the New Jersey cannabis statute, protects both applicants and employees against a refusal to hire, discharge, or other adverse action because a person does or does not use cannabis items. It also separately provides that an employee may not be subjected to adverse action solely because cannabinoid metabolites are in bodily fluid as a result of conduct permitted by the Act. Those protections coexist with authority for an employer to maintain a drug- and alcohol-free workplace and prohibit cannabis use or intoxication during work hours. The table helps separate those provisions rather than treating either one as the whole answer.
Scenario one: the positive result is the whole explanation
The first scenario is a test result with no identified evidence of cannabis use or impairment while the person was working. A laboratory may report cannabinoid metabolites even though the result does not establish when cannabis was used or whether the individual was impaired at a particular shift. The NJ-CRC explains that cannabis can remain in bodily fluids for a long period and that there is no perfect test for present cannabis impairment.
That scientific limitation matters because New Jersey’s statute and the Commission’s guidance draw a line between a test result and adverse employment action based on it alone. The statute authorizes scientifically reliable objective testing methods and procedures, including blood, urine, or saliva testing, in specified circumstances. Yet the Commission states that a scientifically reliable test showing metabolites in bodily fluid alone is insufficient to support an adverse employment action.
This does not mean that every test itself is forbidden. CREAMMA permits testing upon reasonable suspicion of cannabis use while performing work responsibilities, observable signs of intoxication related to cannabis use, or a work-related accident under investigation. It also permits random testing, pre-employment screening, and regular screening of current employees to determine use during prescribed work hours. An authorized collection or screen and a justified decision to suspend, decline to hire, or discharge are different steps in the analysis.
For an applicant, the initial issue may be especially easy to obscure. A recruiter may say only that a screening was “not cleared,” while the written job materials may identify a regulated position or may say nothing about one. For a current employee, a routine or random screen may be followed by a short letter that does not mention any work-time behavior. In either setting, the exact explanation given for the decision is more informative than a bare “positive” notation.
The inquiry should also stay limited to cannabis-testing discipline. It does not turn a positive test into proof of unlawful treatment, and it does not require an employer to allow cannabis at work. It focuses instead on whether a result standing alone is being treated as conclusive when the applicable state-law framework distinguishes metabolites from workplace impairment.
Scenario two: the employer alleges impairment while you were working
The second scenario has a different factual center. The employer may point to a supervisor’s observation, an accident investigation, a report of use during a shift, a safety incident, or another asserted violation that occurred during prescribed work hours. New Jersey law permits testing when there is reasonable suspicion that an employee used a cannabis item while working, observable signs of intoxication related to cannabis use, or a work-related accident the employer is investigating.
In this setting, the question is not whether the employer may invoke safety or investigate an incident. The question is what its actual record shows. The NJ-CRC recommends evidence-based protocols that document observed behavior and physical signs to develop reasonable suspicion, with a drug test used to verify recent use of an impairing substance. Its guidance describes a uniform reasonable-suspicion observation report that can record behavior, physical signs, and evidence from work hours.
The guidance also recognizes interim workplace arrangements while the Commission formulates and approves Workplace Impairment Recognition Expert certification standards. It says an employer may designate a sufficiently trained interim staff member, or use another manager or supervisor, to assist with the observation process. A cognitive impairment test or ocular scan may also be used as evidence in developing reasonable suspicion. These examples do not make every observation definitive; they show why the source, timing, specificity, and consistency of the claimed evidence matter.
A useful comparison is between a disciplinary memo that recites a positive result with no description of the shift and a memo that identifies who saw what, when it was observed, what workplace event triggered the investigation, and how the test fit into the decision. They are materially different records. The Commission’s published position is that a metabolite test paired with evidence-based documentation of physical signs or other impairment evidence during prescribed work hours may be sufficient to support adverse action; it does not say that a result erases the need for that separate evidence.
The policy in force can supply important context. A handbook may address testing, reporting a workplace accident, a fitness-for-duty determination, or paid versus unpaid investigatory leave. A collective bargaining agreement or an individual employment agreement may contain separate procedures. Those documents do not override applicable law, but their actual terms can bear on what the employer claims happened and whether it followed the procedure it chose.
Scenario three: a federally regulated duty can follow different rules
The third scenario begins with the job, not just the employer’s industry or a generic “safety-sensitive” label. CREAMMA preserves an employer’s ability to revise employee prohibitions consistent with federal law, rules, and regulations if the state-law provisions result in a provable adverse impact on an employer subject to federal-contract requirements. That language is a defined condition, rather than a universal exception for every business that serves a government customer.
Federal transportation rules illustrate why the job-specific question matters. The U.S. Department of Transportation states that people in DOT safety-sensitive transportation positions remain subject to marijuana testing. Its notice gives examples including pilots, school-bus and truck drivers, train engineers, subway operators, certain aircraft maintenance personnel, ship captains, and pipeline emergency-response personnel. The fact that New Jersey permits adult-use cannabis does not change those federal testing requirements.
Under DOT regulations, an employer that receives a verified positive drug-test result must immediately remove the employee from safety-sensitive functions. The employer may not return the employee to those functions unless and until the employee successfully completes the applicable federal return-to-duty process. Removal from the covered function is not necessarily a complete answer to every employment-status question, but it is an important federal constraint that differs from a New Jersey metabolite-only analysis.
Not every worker whose role involves machinery, customers, health care, construction, public safety, or driving is covered by a DOT rule. Nor does a job title establish whether a federal agency regulation, license, funding condition, contract requirement, or testing program governs. The relevant materials may include the job description, the employer’s policy, the federal program named in the policy, and the actual duties the employee performed. Those details are particularly important before treating a reference to federal law as either automatically decisive or irrelevant.
Compare the stated rationale with the scenario the employer invokes
Once the applicable scenario is clear, the next task is to test the employer’s stated rationale against it. This means reading the words chosen in the offer withdrawal, suspension notice, discharge letter, test paperwork, and policy rather than supplying a reason that is not in the record. “Positive drug test,” “observed impairment,” “post-accident investigation,” and “federal safety-sensitive position” are not interchangeable explanations.
If the stated rationale is only a positive result, the central distinction is whether the decision rests solely on metabolites from conduct permitted by CREAMMA. If the employer instead alleges impairment at work, the relevant comparison is between the allegation and the contemporaneous account: the time and place, persons who observed the event, reported behavior or physical signs, the accident facts if any, and the connection between that evidence and the test. If the employer invokes a federal obligation, the role and governing rule need to be identified rather than assumed from a company-wide policy.
Timing can reveal which comparison applies. A test conducted after an alleged accident has a different starting point from a pre-employment screen. A termination following a manager’s same-shift observation differs from an action after a random test with no workplace event identified. Similarly, an employer may treat temporary removal from a particular duty, administrative leave, disqualification from a role, and termination as distinct actions. The fact-specific reason for each action should be kept separate.
This approach also avoids an overbroad answer to the question, “Can my employer test for cannabis?” The statute permits several kinds of testing. It also protects against certain adverse employment action. A defensible assessment must account for both provisions, the evidence claimed, and any independent federal framework. The firm’s support for employees confronting contested workplace decisions is directed to fact-specific review of that kind of record.
Documents to preserve before the record disappears
Records often clarify the scenario before memories do. Preserve the job posting and offer materials, the policy or handbook version supplied to the employee, test notices and results, chain-of-custody or medical-review paperwork received, observation reports, accident reports, emails or messages about the event, and each letter about leave, suspension, qualification, discipline, or separation. Keep copies in the form received and note the dates of conversations, reports, tests, and action notices. Do not alter workplace records or assume that a document labeled “confidential” can be broadly shared; its terms and the circumstances may matter.
For a claimed impairment event, a contemporaneous written account may help preserve what was said and what was observed. For a claimed federal-duty issue, the job description, certifications, route or assignment records, and policy language may be especially important. For a withdrawn offer, the posting, conditional-offer documents, screening instruction, and explanation of the decision can help distinguish a general screen from a stated regulated-role requirement.
A prompt, document-specific review can be useful when a person is asked to sign a discipline or separation document, removed from a covered duty, placed on leave after testing, or told an offer is no longer available. To discuss the circumstances and available records in confidence, request a confidential consultation.
This article provides general legal information, not legal advice. Cannabis workplace issues depend on the facts, job duties, policies, agreements, and laws that apply to a particular situation; reading this article does not create an attorney-client relationship.